Prognostic value of quantitative flow ratio in patients with coronary heart disease after percutaneous coronary

Huaigang Chen1,2, Lang Hong2, Gang Xi3

  • 1Medical College of Nanchang University, Nanchang, China.

Insights

Quantitative flow ratio (QFR) effectively predicts adverse cardiac events after percutaneous coronary intervention (PCI). Lower post-PCI QFR values indicate a higher risk of major adverse cardiac events, highlighting QFR

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Diagnostic Imaging

Background:

  • Coronary atherosclerotic heart disease poses significant health risks.
  • Current prognostic assessment methods after percutaneous coronary intervention (PCI) are suboptimal.
  • There is a clinical need for improved methods to predict patient outcomes post-PCI.

Purpose of the Study:

  • To evaluate the predictive capability of quantitative flow ratio (QFR) for adverse events following PCI.
  • To determine the association between post-PCI QFR values and major adverse cardiac events, including vessel-oriented composite endpoints and target lesion failure.

Main Methods:

  • A meta-analysis was conducted on eight studies comprising 4,173 patients and 5,688 vascular lesions.
  • Data extraction and quality assessment were performed on clinical trials investigating QFR and adverse cardiac events post-PCI.
  • Pooled hazard ratios (HR) and relative risks (RR) were calculated to assess the relationship between QFR and adverse outcomes.

Main Results:

  • A pooled HR of 4.72 (95% CI: 3.29-6.75) indicated that QFR is a significant predictor of adverse events post-PCI.
  • Lower post-PCI QFR values were strongly associated with an increased risk of individual clinical events.
  • Specific relative risks were observed for cardiac death (RR: 6.51), myocardial infarction (RR: 4.83), and target vessel revascularization (RR: 4.21).

Conclusions:

  • Quantitative flow ratio (QFR) demonstrates substantial potential for prognostic assessment in patients undergoing PCI.
  • Measuring QFR post-PCI is crucial for accurate risk stratification.
  • A reduced post-PCI QFR value serves as a critical indicator of increased risk for adverse cardiovascular events.
Abstract